Global Diabetes Devices Market was valued at USD XX Billion in the year 2021. Global Diabetes Devices Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Diabetes Devices Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Blood Glucose Monitoring Systems, Lancets, Test Strips or Test Papers, Insulin Delivery Devices, Diabetes Management Mobile Applications. In which Blood Glucose Monitoring Systems for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as Abbott Laboratories, ACON Laboratories, Inc., Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG), Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, and Terumo Corporation.

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 DIABETES DEVICES TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 BLOOD GLUCOSE MONITORING DEVICES
5.5.1 TESTING STRIPS
5.5.2 SELF-MONITORING BLOOD GLUCOSE METERS
5.5.3 LANCETS
5.5.4 CONTINUOUS GLUCOSE MONITORS
5.6 INSULIN DELIVERY DEVICES
5.6.1 INSULIN SYRINGES
5.6.2 INSULIN PENS
5.6.3 INSULIN PUMPS
5.6.4 INSULIN JET INJECTORS
5.7 DIABETES MANAGEMENT MOBILE APPLICATIONS
6 DIABETES DEVICES DISTRIBUTION CHANNELS ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET DISTRIBUTION CHANNELS ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 HOSPITAL PHARMACIES
6.6 RETAIL PHARMACIES
6.7 ONLINE PHARMACIES
6.8 DIABETES CLINICS
6.9 OTHERS
7 DIABETES DEVICES MARKET APPLICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 HOSPITAL
7.6 HOMECARE
7.7 DIAGNOSTIC CENTERS
8 GLOBAL DIABETES DEVICES REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.2.3 Y-O-Y GROWTH TREND ANALYSIS
8.2.3.1 U.S.
8.2.3.2 Canada
8.2.3.3 Mexico
8.3 ASIA-PACIFIC
8.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.3.2 Y-O-Y GROWTH TREND ANALYSIS
8.3.2.1 China
8.3.2.2 Japan
8.3.2.3 Korea
8.3.2.4 India
8.3.2.5 Southeast Asia
8.4 MIDDLE EAST AND AFRICA
8.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4.3 Y-O-Y GROWTH TREND ANALYSIS
8.4.3.1 Saudi Arabia
8.4.3.2 UAE
8.4.3.3 Egypt
8.4.3.4 Nigeria
8.4.3.5 South Africa
8.5 EUROPE
8.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.5.3 Y-O-Y GROWTH TREND ANALYSIS
8.5.3.1 Germany
8.5.3.2 France
8.5.3.3 UK
8.5.3.4 Russia
8.5.3.5 Italy
8.6 LATIN AMERICA
8.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.6.3 Y-O-Y GROWTH TREND ANALYSIS
8.6.3.1 Brazil
8.6.3.2 Argentina
8.6.3.3 Columbia
9 MARKET PLAYERS
9.1 MEDTRONIC
9.1.1 BUSINESS OVERVIEW:
9.1.2 PRODUCT PORTFOLIO
9.1.3 RECENT DEVELOPMENTS
9.1.4 SWOT ANALYSIS:
9.2 ABBOTT
9.3 ASCENSIA DIABETES CARE HOLDINGS AG (FORMERLY DIABETES CASE BUSINESS OF BAYER AG)
9.4 DEXCOM, INC.
9.5 F. HOFFMANN-LA ROCHE LTD.
9.6 SANOFI
9.7 NOVO NORDISK A/S
9.8 INSULET CORPORATION
9.9 YPSOMED
9.10 VALERITAS, INC
9.11 ACON LABORATORIES, INC.
9.12 BECTON, DICKINSON AND COMPANY
9.13 JOHNSON & JOHNSON
9.14 TERUMO CORPORATION
9.15 ARKRAY, INC.
9.16 ECHO THERAPEUTICS, INC.
9.17 GLYSENS INCORPORATED
9.18 INSULET CORPORATION
9.19 SANOFI
9.20 YPSOMED AG
10 ABOUT US

TABLE 1 DIABETES DEVICES REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 2 GLOBAL DIABETES DEVICES MARKET, 2021–2030, (USD MILLION)
TABLE 3 DIABETES DEVICES CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL DIABETES DEVICES HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL DIABETES DEVICES HISTORICAL MARKET DISTRIBUTION CHANNELS ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL DIABETES DEVICES HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 NORTH AMERICA DIABETES DEVICES HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030 (USD MILLION)
TABLE 13 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 U.S. DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 15 U.S. DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 16 U.S. DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 17 CANADA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 18 CANADA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 19 MEXICO DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 20 MEXICO DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 21 APAC DIABETES DEVICES HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 22 ASIA-PACIFIC DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 23 ASIA-PACIFIC DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030 (USD MILLION)
TABLE 24 ASIA-PACIFIC DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 25 CHINA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 CHINA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 JAPAN DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 28 JAPAN DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 29 KOREA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 30 KOREA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 31 INDIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 32 INDIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 33 SOUTHEAST ASIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 SOUTHEAST ASIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA DIABETES DEVICES HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 39 SAUDI ARABIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 SAUDI ARABIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 UAE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 UAE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 EGYPT DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 44 EGYPT DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 45 NIGERIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 46 NIGERIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 47 SOUTH AFRICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 48 SOUTH AFRICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 49 EUROPE DIABETES DEVICES HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 50 EUROPE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 51 EUROPE DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030 (USD MILLION)
TABLE 52 EUROPE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 53 GERMANY DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 GERMANY DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 FRANCE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 FRANCE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 UK DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 UK DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 RUSSIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 60 RUSSIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 61 ITALY DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 62 ITALY DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 63 LATIN AMERICA DIABETES DEVICES HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 64 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030 (USD MILLION)
TABLE 66 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 67 BRAZIL DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 BRAZIL DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 ARGENTINA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 ARGENTINA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 COLUMBIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 COLUMBIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL DIABETES DEVICES MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 DIABETES DEVICES TYPE ANALYSIS
FIGURE 11 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 DIABETES DEVICES DISTRIBUTION CHANNELS ANALYSIS
FIGURE 13 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 DIABETES DEVICES APPLICATION ANALYSIS
FIGURE 15 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 GLOBAL DIABETES DEVICES CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 17 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 MARKET SHARE BY COUNTRY
FIGURE 19 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 NORTH AMERICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 U.S. DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 23 U.S. DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 CANADA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 CANADA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 MEXICO DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 MEXICO DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 MARKET SHARE BY COUNTRY
FIGURE 29 APAC DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 APAC DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 APAC DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 CHINA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 CHINA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 JAPAN DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 35 JAPAN DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 KOREA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 KOREA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 INDIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 INDIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 SOUTHEAST ASIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 SOUTHEAST ASIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 MARKET SHARE BY COUNTRY
FIGURE 43 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 MIDDLE EAST AND AFRICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 SAUDI ARABIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 SAUDI ARABIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 UAE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 UAE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 EGYPT DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 51 EGYPT DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 NIGERIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 NIGERIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 SOUTH AFRICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 SOUTH AFRICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 MARKET SHARE BY COUNTRY
FIGURE 57 EUROPE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 EUROPE DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 EUROPE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 GERMANY DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 GERMANY DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 FRANCE DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 FRANCE DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 UK DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 UK DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 RUSSIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 67 RUSSIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 ITALY DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 ITALY DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 MARKET SHARE BY COUNTRY
FIGURE 71 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE DISTRIBUTION CHANNELS ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 LATIN AMERICA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 BRAZIL DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 BRAZIL DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 ARGENTINA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 ARGENTINA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 COLUMBIA DIABETES DEVICES CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 COLUMBIA DIABETES DEVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 FINANCIAL OVERVIEW: